{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:23:13Z","timestamp":1789042993520,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81670150"],"award-info":[{"award-number":["81670150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81800160"],"award-info":[{"award-number":["81800160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>B cell lymphoma can co-occur with multiple myeloma (MM), and the prognosis in this case is usually poor. We propose the combination of CD19-chimeric antigen receptor (CAR) T cells and BCMA-CAR T cells for the treatment of such patients to obtain a superior prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present a 50-year-old patient with previous B cell lymphoma and subsequent multiple myeloma (MM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>A diagnosis of B cell lymphoma and MM was made.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with a combination of haploidentical CD19-chimeric antigen receptor (CAR) T cells and BCMA-CAR T cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After CAR T cell therapy, the monoclonal plasma cells in the bone marrow and M protein disappeared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The combination therapy of CD19- and BCMA-CAR T cells is an effective measure to treat patients with concomitant or borderline cases of B cell lymphoma and MM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019739","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T15:45:52Z","timestamp":1587224752000},"page":"e19739","source":"Crossref","is-referenced-by-count":4,"title":["Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy"],"prefix":"10.1097","volume":"99","author":[{"given":"Tongjuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood.V118.21.1590.1590","article-title":"B cell lymphoma in association with multiple myeloma analysis of the biologic relationship","volume":"118","author":"Mahindra","year":"2011","journal-title":"Blood"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0092-8674(89)90943-4","article-title":"Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice","volume":"58","author":"Becker","year":"1989","journal-title":"Cell"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hon.2568","article-title":"The acceleration of CAR-T therapy in non-Hodgkin lymphoma","volume":"37","author":"Munshi","year":"2019","journal-title":"Hematol Oncol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","article-title":"T cells genetically modified to express an anti\u2013B-Cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma","volume":"36","author":"Brudno","year":"2018","journal-title":"J Clin Oncol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1200\/JCO.2018.36.15_suppl.8007","article-title":"bb2121 anti-BCMA CAR T-cell therapy in patients with relapsedrefractory multiple myeloma Updated results from a multicenter phase I study","volume":"36","author":"Raje","year":"2018","journal-title":"J Clin Oncol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13045-018-0681-6","article-title":"A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma","volume":"11","author":"Zhao","year":"2018","journal-title":"J Hematol Oncol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/annonc\/mdv304","article-title":"Clinical practice guidelines diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann Oncol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3904\/kjim.1994.9.2.113","article-title":"A case of coincident multiple myeloma and NHL","volume":"9","author":"Lee","year":"1994","journal-title":"Korean J Intern Med"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000206117","article-title":"Coincident multiple myeloma and non-Hodgkin's lymphoma with 2 serum monoclonal immunoglobulins","volume":"75","author":"Grau","year":"1986","journal-title":"Acta Haematol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/0377-4929.188110","article-title":"Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma","volume":"59","author":"Mitra","year":"2016","journal-title":"Indian J Pathol Microbiol"},{"key":"R13-20230915","first-page":"772","article-title":"Simultaneous occurrence of multiple myeloma and Hodgkin's disease: a case report","volume":"85","author":"Lalayanni","year":"2000","journal-title":"Haematologica"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3892\/ol.2014.2185","article-title":"Simultaneous occurrence of two B-cell malignancies: a case report","volume":"8","author":"Zhou","year":"2014","journal-title":"Oncol Lett"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.3892\/ol.2016.4503","article-title":"Simultaneous occurrence of Hodgkin's lymphoma and multiple myeloma: a case report and review of the literature","volume":"11","author":"Huang","year":"2016","journal-title":"Oncol Lett"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00277-014-2226-6","article-title":"Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma","volume":"94","author":"Johnston","year":"2015","journal-title":"Ann Hematol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3960\/jslrt.16020","article-title":"Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic plasma cell myeloma","volume":"57","author":"Aoyama","year":"2017","journal-title":"J Clin Exp Hematopathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:18:56Z","timestamp":1694823536000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":17,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019739","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}